Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.890
+0.070 (3.85%)
Nov 22, 2024, 4:00 PM EST - Market closed
Metagenomi Employees
Metagenomi had 236 employees as of December 31, 2023.
Employees
236
Change
n/a
Growth
n/a
Revenue / Employee
$233,390
Profits / Employee
-$313,364
Market Cap
70.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 236 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 389 |
| Champions Oncology | 210 |
| Celularity | 120 |
| Boundless Bio | 72 |
| Immuneering | 68 |
| enVVeno Medical | 31 |
| Aileron Therapeutics | 15 |
MGX News
- 15 hours ago - The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Metagenomi Inc - Accesswire
- 17 hours ago - DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024 - GlobeNewsWire
- 1 day ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 2 days ago - Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGX - GlobeNewsWire
- 2 days ago - The Schall Law Firm Invites Investor Participation In A Fraud Case Against Metagenomi Inc - Accesswire
- 3 days ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 4 days ago - MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit - PRNewsWire
- 4 days ago - The Schall Law Firm Invites Investors To Join A Fraud Case Against Metagenomi Inc - Accesswire